97.50
-12.50
(-11.36%)
As of 8:15:22 AM GMT+2. Market Open.
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 10 | 9 | 12 | 13 |
Avg. Estimate | 631.36M | 657.39M | 2.62B | 2.78B |
Low Estimate | 622M | 648.43M | 2.57B | 2.65B |
High Estimate | 635.76M | 667.82M | 2.65B | 2.95B |
Year Ago Sales | 652.7M | 673.5M | 2.63B | 2.62B |
Sales Growth (year/est) | -3.27% | -2.39% | -0.14% | 5.96% |
EPS Trend
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
WL9.F | -- | -- | -- | -- |
S&P 500 | 6.55% | 6.50% | 9.70% | 14.29% |
Upgrades & Downgrades
Maintains | Mizuho: Outperform to Outperform | 2/10/2025 |
Maintains | Barclays: Equal-Weight to Equal-Weight | 2/10/2025 |
Maintains | Keefe, Bruyette & Woods: Outperform to Outperform | 2/7/2025 |
Maintains | UBS: Neutral to Neutral | 2/7/2025 |
Maintains | Wells Fargo: Equal-Weight to Equal-Weight | 2/7/2025 |
Downgrade | William Blair: Outperform to Market Perform | 2/7/2025 |